Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

A. Vennegoor, T. Rispens, E.M.M. Strijbis, A. Seewann, B.M.J. Uitdehaag, L.J. Balk, F. Barkhof, C.H. Polman, G. Wolbink, J. Killestein

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)593-600
JournalMultiple Sclerosis
Issue number5
Publication statusPublished - 2013

Cite this